Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Page 1
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study.
Bikdeli B, Muriel A, Wang Y, Piazza G, Khairani CD, Rosovsky RP, Mehdipoor G, O'Donoghue ML, Madridano O, Lopez-Saez JB, Mellado M, Brasero AMD, Grandone E, Spagnolo PA, Lu Y, Bertoletti L, López-Jiménez L, Núñez MJ, Blanco-Molina Á, Gerhard-Herman M, Goldhaber SZ, Bates SM, Jimenez D, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. Among authors: bates sm. Semin Thromb Hemost. 2023 Oct;49(7):725-735. doi: 10.1055/s-0043-1764231. Epub 2023 Mar 3. Semin Thromb Hemost. 2023. PMID: 36868268
Whether such differences correlate with disparities in treatment or differences in short- or long-term clinical outcomes warrants further investigation....
Whether such differences correlate with disparities in treatment or differences in short- or long-term clinical outcomes warrants fur …
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.
Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ. Callender LA, et al. Among authors: bates sm. Front Immunol. 2020 Aug 11;11:1991. doi: 10.3389/fimmu.2020.01991. eCollection 2020. Front Immunol. 2020. PMID: 32903476 Free PMC article. Review.
We explore how underlying disease etiologies and common therapies used to treat these conditions exacerbate COVID-19 progression. Moreover, we discuss the long-term challenges associated with the use of both novel and repurposed therapies for the treatment of COVID-19 in p …
We explore how underlying disease etiologies and common therapies used to treat these conditions exacerbate COVID-19 progression. Moreover, …
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.
Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S. Douketis JD, et al. Among authors: bates sm. JAMA Intern Med. 2019 Nov 1;179(11):1469-1478. doi: 10.1001/jamainternmed.2019.2431. JAMA Intern Med. 2019. PMID: 31380891 Free PMC article.
Participants (n = 3007) had AF; were 18 years of age or older; were long-term users of apixaban, dabigatran etexilate, or rivaroxaban; were scheduled for an elective surgery or procedure; and could adhere to the DOAC therapy interruption protocol. ...
Participants (n = 3007) had AF; were 18 years of age or older; were long-term users of apixaban, dabigatran etexilate, or rivaroxaban …
Absence of biomarker evidence for early eukaryotic life from the Mesoproterozoic Roper Group: Searching across a marine redox gradient in mid-Proterozoic habitability.
Nguyen K, Love GD, Zumberge JA, Kelly AE, Owens JD, Rohrssen MK, Bates SM, Cai C, Lyons TW. Nguyen K, et al. Among authors: bates sm. Geobiology. 2019 May;17(3):247-260. doi: 10.1111/gbi.12329. Epub 2019 Jan 10. Geobiology. 2019. PMID: 30629323
The dearth of Mesoproterozoic eukaryotic sterane biomarkers, even within the more oxic facies, is somewhat surprising but suggests that controls such as the long-term nutrient balance and other environmental factors may have throttled the abundances and diversity of early …
The dearth of Mesoproterozoic eukaryotic sterane biomarkers, even within the more oxic facies, is somewhat surprising but suggests that cont …
How I treat heavy menstrual bleeding associated with anticoagulants.
Boonyawat K, O'Brien SH, Bates SM. Boonyawat K, et al. Among authors: bates sm. Blood. 2017 Dec 14;130(24):2603-2609. doi: 10.1182/blood-2017-07-797423. Epub 2017 Nov 1. Blood. 2017. PMID: 29092828 Free article.
In the acute setting, the decision to withhold anticoagulants is based on an individual patient's risk of thrombosis and the severity of the bleeding. For women who require long-term anticoagulation, a levonorgestrel intrauterine system, tranexamic acid (during menstrual f …
In the acute setting, the decision to withhold anticoagulants is based on an individual patient's risk of thrombosis and the severity of the …
Montessori-Based Activities Among Persons with Late-Stage Dementia: Evaluation of Mental and Behavioral Health Outcomes.
Wilks SE, Boyd PA, Bates SM, Cain DS, Geiger JR. Wilks SE, et al. Among authors: bates sm. Dementia (London). 2019 May;18(4):1373-1392. doi: 10.1177/1471301217703242. Epub 2017 Apr 27. Dementia (London). 2019. PMID: 28449593
Given the need to understand risks and benefits of treatments for individuals with late-stage dementia, specifically regarding their mental and behavioral health, this study sought to evaluate the effects of a Montessori-based activity program implemented in a long-term ca …
Given the need to understand risks and benefits of treatments for individuals with late-stage dementia, specifically regarding their mental …
Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis.
Geersing GJ, Zuithoff NP, Kearon C, Anderson DR, Ten Cate-Hoek AJ, Elf JL, Bates SM, Hoes AW, Kraaijenhagen RA, Oudega R, Schutgens RE, Stevens SM, Woller SC, Wells PS, Moons KG. Geersing GJ, et al. Among authors: bates sm. BMJ. 2014 Mar 10;348:g1340. doi: 10.1136/bmj.g1340. BMJ. 2014. PMID: 24615063 Free PMC article. Review.
MAIN OUTCOME MEASURES: Multilevel logistic regression models, including an interaction term for each subgroup, were used to estimate differences in predicted probabilities of deep vein thrombosis by the Wells rule. ...
MAIN OUTCOME MEASURES: Multilevel logistic regression models, including an interaction term for each subgroup, were used to estimate …
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].
Zawilska K, Jaeschke R, Tomkowski W, Mayzner-Zawadzka E, Nizankowski R, Olejek A, Pasierski T, Torbicki A, Undas A, Jawień A, Gajewski P, Sznajd J, Brozek J; Working Group for the Polish Guidelines for the Prevention and Treatment of Venous Thromboembolism. Zawilska K, et al. Pol Arch Med Wewn. 2009;119 Suppl 1:1-69. Pol Arch Med Wewn. 2009. PMID: 19841614 Free article. Review. Polish.
Specific recommendations have been formulated for pregnant women, patients requiring surgery while receiving long-term oral anticoagulant treatment, and patients undergoing regional anesthesia and/or analgesia. ...
Specific recommendations have been formulated for pregnant women, patients requiring surgery while receiving long-term oral anticoagu …
Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Bates SM, et al. Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761. Chest. 2008. PMID: 18574280
We suggest that pregnant women with multiple episodes of VTE who are not receiving long-term anticoagulants receive antepartum prophylactic, intermediate-dose, or adjusted-dose LMWH or intermediate or adjusted-dose UFH, followed by postpartum anticoagulants (Grade 2C). For …
We suggest that pregnant women with multiple episodes of VTE who are not receiving long-term anticoagulants receive antepartum prophy …
New anticoagulants.
Weitz JI, Bates SM. Weitz JI, et al. Among authors: bates sm. J Thromb Haemost. 2005 Aug;3(8):1843-53. doi: 10.1111/j.1538-7836.2005.01374.x. J Thromb Haemost. 2005. PMID: 16102051 Free article. Review.
However, ximelagatran produces a three-fold elevation in alanine transaminase levels in 7.9% of patients treated for more than a month, the long-term significance of which is uncertain. Whether other direct thrombin inhibitors or inhibitors of factors Xa or IXa also have t …
However, ximelagatran produces a three-fold elevation in alanine transaminase levels in 7.9% of patients treated for more than a month, the …
15 results